1. Home
  2. GBIO vs GFAI Comparison

GBIO vs GFAI Comparison

Compare GBIO & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • GFAI
  • Stock Information
  • Founded
  • GBIO 2016
  • GFAI 2018
  • Country
  • GBIO United States
  • GFAI Singapore
  • Employees
  • GBIO N/A
  • GFAI N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • GBIO Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • GBIO 23.2M
  • GFAI 20.7M
  • IPO Year
  • GBIO 2020
  • GFAI N/A
  • Fundamental
  • Price
  • GBIO $0.39
  • GFAI $1.01
  • Analyst Decision
  • GBIO Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • GBIO 4
  • GFAI 2
  • Target Price
  • GBIO $7.33
  • GFAI $6.75
  • AVG Volume (30 Days)
  • GBIO 559.5K
  • GFAI 329.7K
  • Earning Date
  • GBIO 05-12-2025
  • GFAI 04-28-2025
  • Dividend Yield
  • GBIO N/A
  • GFAI N/A
  • EPS Growth
  • GBIO N/A
  • GFAI N/A
  • EPS
  • GBIO N/A
  • GFAI N/A
  • Revenue
  • GBIO $19,892,000.00
  • GFAI $35,841,743.00
  • Revenue This Year
  • GBIO N/A
  • GFAI $0.37
  • Revenue Next Year
  • GBIO $10.90
  • GFAI $5.60
  • P/E Ratio
  • GBIO N/A
  • GFAI N/A
  • Revenue Growth
  • GBIO 236.92
  • GFAI 1.78
  • 52 Week Low
  • GBIO $0.32
  • GFAI $0.76
  • 52 Week High
  • GBIO $4.34
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 43.58
  • GFAI 48.56
  • Support Level
  • GBIO $0.34
  • GFAI $0.78
  • Resistance Level
  • GBIO $0.40
  • GFAI $1.07
  • Average True Range (ATR)
  • GBIO 0.05
  • GFAI 0.09
  • MACD
  • GBIO 0.01
  • GFAI 0.02
  • Stochastic Oscillator
  • GBIO 61.29
  • GFAI 80.65

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.

Share on Social Networks: